nad has been researched along with methyl-thiohydantoin-tryptophan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hou, Y; Wang, X; Yu, J; Zhao, L; Zhong, B | 1 |
1 other study(ies) available for nad and methyl-thiohydantoin-tryptophan
| Article | Year |
|---|---|
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1).
Topics: Apoptosis; Humans; Imidazoles; Indoles; NAD; NAD(P)H Dehydrogenase (Quinone); Quinones; Receptor-Interacting Protein Serine-Threonine Kinases; Serine; Threonine | 2021 |